The Top Reasons Latin America Could Dominate the Cannabis Market

The Latin America cannabis market is on pace to be one of the most exciting in the world. In fact, it has the potential to become one of the largest markets in the world with an estimated value of $9.8 billion, according to New Frontier Data. Better, according to Health Europa, the Latin American market is projected to reach a total value of $12.7 billion by 2028 thanks to a combination the region’s combination of favorable weather conditions, low overhead costs.
That’s creating sizable opportunity for companies including Terrace Global Inc. (TSXV:TRCE), Charlotte’s Web Holdings Inc. (OTC:CWBHF)(CN:CWEB), Aurora Cannabis Inc. (NYSE:ACB)(TSX:ACB), The Supreme Cannabis Company Inc. (TSX:FIRE)(OTC:SPRWF), and Marimed Inc. (OTC:MRMD).

Terrace Global Inc. (TSXV:TRCE) BREAKING NEWS: Terrace Global Inc. provide an operational update at its hemp cultivation sites in Uruguay and Spain. In Uruguay, the Company, through its wholly-owned subsidiary, Oransur, S.A., operates a high-CBD hemp facility with greenhouse and outdoor cultivation based in San Fernando. In Spain, the Company, through its wholly-owned subsidiary, Pharmabinoide SRL, operates an outdoor CBD hemp facility in Jaen.

“Terrace Global is fortunate to have a very strong balance sheet with approximately $17 million in cash at year end. Given the cyclical nature of our outdoor cultivation operations, we have the ability to scale-up and scale-down operations without impacting our long-term business plan. Our current focus is on receiving the requisite approvals in Portugal to commence construction of our medical cannabis greenhouse facilities in Portugal,” commented Francisco Ortiz von Bismarck, Chief Executive Officer of Terrace Global.

Oransur Operational Update -- In 2019, Oransur planted four varieties of hemp in San Fernando, Uruguay, including two high-CBD strains sourced from Colorado – Cherry Wine (10% CBD) and Cherry Blossom (15% CBD) in accordance with Good Agricultural and Collection Practices (GACP). These high-CBD strains were grown as seedlings and ultimately planted outdoors producing approximately 750 kilograms of high CBD biomass for extraction. The high CBD-strains results produced germination rates of between 88% and 95%, respectively. Oransur was also able to produce approximately 500 kilograms of high-CBD seeds which the are in the process of being sold in the international markets pursuant to applicable import/export regulations. Please visit to see a high-resolution video illustrating the Oransur outdoor cultivation project.

“Oransur and Pharmabinoide presented interesting operational results through the end of 2019 to present. We saw in Oransur that our high CBD genetics sourced from Colorado performed very well in San Fernando where we were able to produce approximately 750 kilograms of high CBD biomass. We envision our Uruguay sourced biomass to ultimately be extracted in the E.U. under a medical cannabis regime, which represents a very attractive business model given the cost structure,” commented Stephen Lermer, President and Chief Operating Officer of Terrace Global. “In addition to this biomass, we were able to produce approximately 500 kilograms of high-CBD seeds for commercial sale. We have seen the market price for high-CBD seeds fluctuate globally, but we nonetheless see these seeds as an unexpected windfall for the Company and see the potential for a seed business developing in Uruguay with a view to global supply.”

Pharmabinoide Operational Update -- Pharmabinoide has recently completed its second outdoor hemp harvest in Jaen, Spain. Pharmabiniode successfully planted approximately 20 hectares of European certified hemp genetics (Future, Fedora and Felina) in early April 2019. These three varieties resulted in approximately 30 tonnes of biomass for extraction. On March 4, 2020, Pharmabinoide entered into a non-binding letter of intent with Pharma Life Now SL for the purchase and sale of up to 30 tonnes of hemp biomass for extraction at a price of €2.00 per kilogram per % of CBD. Given the current mandatory lock-down in Spain of non-essential services, the parties are in discussions with respect to how to complete the terms of the LOI. As of the date hereof, PharmaLife has purchased 400 kilograms of hemp from Pharmabinoide.

COVID-19 Response -- In response to the novel coronavirus the board of directors of the Company has been monitoring the operations of the Company in Uruguay, Spain and Portugal with a view to ensuring the strength of the Company’s balance sheet. As of year-end, the Company had approximately $17 million in cash and was fully funded to build out its medical cannabis greenhouse facilities in Portugal and its proposed extraction facility. The Company has suspended all non-essential operations and will continue to monitor the global outlook and continues to expect to break ground later this year on its medical cannabis greenhouse facilities in Portugal subject to applicable municipal and regulatory approvals.

The Company is in communications with the municipalities in which it operates to determine how it can assist with the procurement of personal protective equipment (PPE). The Company expects to be in a position to provide certain PPE to the municipalities of Palmela and Constancia, Portugal, later this month as a way to support local front-line workers.

Other cannabis-related developments from around the markets include:

Charlotte’s Web Holdings Inc. (OTC:CWBHF)(CN:CWEB) announced that David Panter has joined the Company as Chief Operating Officer, effective March 30, 2020. Mr. Panter brings over 20 years of broad global supply chain experience at leading cosmetic, agriculture, pharmaceutical, medical device and consumer packaged goods (CPG) companies, including Estée Lauder Company, Luxottica Retail, Campbell Soup Company, and Tyco Healthcare/Covidien. Most recently, at Estée Lauder Company, Mr. Panter was responsible for optimizing the global supply chain including the manufacturing locations and distribution networks in North America, Europe, Asia Pacific and Latin America. Throughout his successful career, he has led manufacturing facilities, quality, distribution and warehouse locations across multiple product categories and has been responsible for transforming operations through continuous improvement, coaching, strategy development and tactical execution.

Aurora Cannabis Inc. (NYSE:ACB)(TSX:ACB) announced its financial and operational results for the second quarter of fiscal 2020 ended December 31, 2019. "Despite delivering modest growth in our core medical and consumer business in Q2, we took immediate and deliberate actions to align our Company to current market conditions," said Michael Singer, Executive Chairman and Interim CEO, Aurora Cannabis. "As announced last week, being a profitable cannabis company for our investors is the singular near-term focus for Aurora and we have begun to implement a business transformation plan where we intend to manage the business with a high degree of fiscal discipline."

The Supreme Cannabis Company Inc. (TSX:FIRE)(OTC:SPRWF) announced the completion of its first international cannabis shipment from Canada into Israel. Supreme Cannabis partnered with Breath of Life International Ltd., Israel’s largest and leading producer of medical cannabis and cannabis products, to offer Truverra-branded premium medical cannabis to patients in Israel. “This transaction represents a new international revenue opportunity for Supreme Cannabis and builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world,” said Colin Moore, Interim President and CEO of Supreme Cannabis. “With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of Health and Ministry of Agriculture and Rural Development. We benefitted from BOL Pharma’s skilled team, international experience and solidified position as a leading medical cannabis company in Israel. As we pursue capital-light international opportunities, we will continue to look to Jeff Adams, Truverra’s CEO, and his exceptional team to build Truverra’s medical brand globally.”

Marimed Inc. (OTC:MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, announced today that Betty's Eddies™, its proprietary, in-house award-winning national cannabis brand, will now be available for retail purchase in Nevada. The expansion is part of MariMed’s plan to increase the licensing and distribution of its proprietary Brands and Products into high-growth legal state markets. Betty’s Eddies has been one of the top performing cannabis brands in multiple states across the country, earning the LeafLink award for Best Selling Medical Product in 2019.  Betty's Eddies are gluten-free, vegan fruit chews made from organically grown fruits and vegetables. Containing full spectrum cannabis oil, Betty’s Eddies are produced in a wide variety of dosages and flavors, also offering limited edition varieties by market. Betty’s Bedtime variety has proven to be a top seller in all markets, helping our customers achieve much needed rest and sleep. In Nevada, MariMed has partnered with Solace Holdings at their state-of-the-art licensed production and manufacturing facility in Las Vegas.  A variety of Betty’s Eddies are now being sold in Nevada, and can be found at Nuwu Dispensary in Elko, Nevada, with several more retail locations to be added this month.

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of and Terrace Global Inc., Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Terrace Global Inc. We own ZERO shares of Terrace Global Inc. Please click here for full disclaimer.

Contact Information:
[email protected]